*Dietary Reference Intake not established.
Other ingredients: magnesium stearate. May contain < 0.2% Povidone K-30
USP24 or precipitated silica. Capsule: hypromellose, sorbitol, silicon
dioxide, water.
AOR guarantees that no
ingredients not listed on the label have been added to the product.
Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish or
shellfish.
Suggested Use
Take one to eight capsules daily, or as directed by a qualified health
care practitioner.
Main Applications
As reported by literature:
• Healthy Lipoprotein Balance
• Circulation
• Skin Health
Source
Pharmaceutical Synthesis
Pregnancy / Nursing
No studies; best to avoid
Cautions
• While there are no reports of liver toxicity associated with inositol
hexanicotinate, it is recommended that regular liver enzyme tests be
done in consultation with a physician. Check with your health care
professional immediately if any of the following side effects occur:
darkening of urine; light gray-colored stools; loss of appetite; severe
stomach pain; yellow eyes or skin. Do not take any form of niacin if you
have existing liver disease.
• Likewise, while no trials have reported the following issues with
inositol hexanicotinate, they have been reported in trials with
conventional niacin supplementation and the following cautions must also
apply: • Niacin may exacerbate peptic/duodenal ulcer, gout, or arterial
bleeding. Consult your physician.
• Infrequent side effects of conventional niacin, seen in < 5% of
high-dose users, include unusually fast, slow, or irregular heartbeat;
difficulty urinating or unusually large volume of urine; loss of
appetite; and unexpected weight loss.
• Some people taking niacin experience nasal inflammation, shortness of
breath, or unusual thirst, sweating, tiredness, or weakness.
• Niacin may lower blood pressure. When combined with blood-pressure
lowering drugs, this may lead to postural hypotension (lightheadedness
or dizziness upon standing up suddenly).
• A small number of people have reported blurring or darkening of vision
related to use of conventional niacin, caused by a swelling of the
macula of the eye. These symptoms resolve themselves after one month of
discontinued use.
• It was once believed that niacin would raise blood glucose levels in
diabetics; however, this result was based on chance observations and
short-term studies. Several long-term trials have now shown that niacin
is safe for diabetics.
• Niacin may alter laboratory tests of thyroid hormones; however, the
clinical significance of these changes, are not clear.
*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure,
or prevent any disease.
The information and product descriptions
appearing on this website are for information purposes only, and are not
intended to provide medical advice to individuals. Consult with your
physician if you have any health concerns, and before initiating any new
diet, exercise, supplement, or other lifestyle changes.
.. Information courtesy of AOR .
|
